Together, the data presented here support the suggestion that VDAC1 depletion in cancer cells leads to metabolic reprogramming, which via different molecular processes mediated by TFs and epigenetics, directed the tumour cells to more differentiated stages. The gene discussed is VDAC1; the disease is cancer.